NCT06171685
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06171685
Title MMRC Horizon One: RRMM (MMRC-099)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Multiple Myeloma Research Consortium
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Emory Winship Cancer Center Atlanta Georgia 30322 United States Details
University of Chicago Cancer Center Chicago Illinois 60637 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute/Harvard Medical School Boston Massachusetts 02215 United States Details
Barbara Ann Karmanos Cancer Center Detroit Michigan 48201 United States Details
Mayo Clinic Rochester Rochester Minnesota 55905 United States Details
Washington University Medicine St Louis Missouri 63110 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10022 United States Details
Mt. Sinai School of Medicine New York New York 10029 United States Details
Atrium Levine Cancer Institute Charlotte North Carolina 28203 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field